A detailed history of Group One Trading, L.P. transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 4,118 shares of ATHA stock, worth $2,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,118
Previous 9,118 54.84%
Holding current value
$2,882
Previous $24,000 58.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.92 - $2.71 $9,600 - $13,550
-5,000 Reduced 54.84%
4,118 $10,000
Q1 2024

May 10, 2024

BUY
$2.24 - $4.15 $20,424 - $37,839
9,118 New
9,118 $24,000
Q2 2022

Aug 11, 2022

BUY
$2.74 - $13.43 $131,188 - $643,014
47,879 Added 45.5%
153,115 $467,000
Q1 2022

May 12, 2022

BUY
$8.96 - $13.51 $290,339 - $437,778
32,404 Added 44.49%
105,236 $1.42 Million
Q4 2021

Feb 11, 2022

BUY
$9.17 - $16.39 $627,310 - $1.12 Million
68,409 Added 1546.67%
72,832 $949,000
Q3 2021

Nov 12, 2021

BUY
$9.15 - $11.09 $40,470 - $49,051
4,423 New
4,423 $41,000

Others Institutions Holding ATHA

About Athira Pharma, Inc.


  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $26.5M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.